nodes	percent_of_prediction	percent_of_DWPC	metapath
Flecainide—CYP2C9—Estropipate—osteoporosis	0.168	0.416	CbGbCtD
Flecainide—CYP2C9—Cholecalciferol—osteoporosis	0.0863	0.215	CbGbCtD
Flecainide—CYP2D6—Cholecalciferol—osteoporosis	0.079	0.196	CbGbCtD
Flecainide—CYP2C9—Estradiol—osteoporosis	0.0696	0.173	CbGbCtD
Flecainide—Mefloquine—CYP19A1—osteoporosis	0.0139	1	CrCbGaD
Flecainide—Headache—Etidronic acid—osteoporosis	0.000719	0.00123	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000715	0.00122	CcSEcCtD
Flecainide—Asthenia—Estropipate—osteoporosis	0.000712	0.00122	CcSEcCtD
Flecainide—Visual impairment—Estradiol—osteoporosis	0.000712	0.00122	CcSEcCtD
Flecainide—Anorexia—Pamidronate—osteoporosis	0.000711	0.00122	CcSEcCtD
Flecainide—Arthralgia—Zoledronate—osteoporosis	0.000711	0.00122	CcSEcCtD
Flecainide—Chest pain—Zoledronate—osteoporosis	0.000711	0.00122	CcSEcCtD
Flecainide—Myalgia—Zoledronate—osteoporosis	0.000711	0.00122	CcSEcCtD
Flecainide—Palpitations—Conjugated Estrogens—osteoporosis	0.00071	0.00122	CcSEcCtD
Flecainide—Insomnia—Risedronate—osteoporosis	0.00071	0.00122	CcSEcCtD
Flecainide—Anxiety—Zoledronate—osteoporosis	0.000708	0.00121	CcSEcCtD
Flecainide—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000706	0.00121	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000706	0.00121	CcSEcCtD
Flecainide—Paraesthesia—Risedronate—osteoporosis	0.000704	0.00121	CcSEcCtD
Flecainide—Pruritus—Estropipate—osteoporosis	0.000702	0.0012	CcSEcCtD
Flecainide—Discomfort—Zoledronate—osteoporosis	0.000702	0.0012	CcSEcCtD
Flecainide—Asthenia—Alendronate—osteoporosis	0.000702	0.0012	CcSEcCtD
Flecainide—Cough—Conjugated Estrogens—osteoporosis	0.000701	0.0012	CcSEcCtD
Flecainide—Dyspnoea—Risedronate—osteoporosis	0.000699	0.0012	CcSEcCtD
Flecainide—Hypotension—Pamidronate—osteoporosis	0.000697	0.00119	CcSEcCtD
Flecainide—Convulsion—Conjugated Estrogens—osteoporosis	0.000696	0.00119	CcSEcCtD
Flecainide—Dry mouth—Zoledronate—osteoporosis	0.000695	0.00119	CcSEcCtD
Flecainide—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000695	0.00119	CcSEcCtD
Flecainide—Fatigue—Ethinyl Estradiol—osteoporosis	0.000694	0.00119	CcSEcCtD
Flecainide—Pruritus—Alendronate—osteoporosis	0.000692	0.00119	CcSEcCtD
Flecainide—Dyspepsia—Risedronate—osteoporosis	0.000691	0.00118	CcSEcCtD
Flecainide—Eye disorder—Estradiol—osteoporosis	0.000691	0.00118	CcSEcCtD
Flecainide—Tinnitus—Estradiol—osteoporosis	0.000689	0.00118	CcSEcCtD
Flecainide—Constipation—Ethinyl Estradiol—osteoporosis	0.000688	0.00118	CcSEcCtD
Flecainide—Confusional state—Zoledronate—osteoporosis	0.000687	0.00118	CcSEcCtD
Flecainide—Flushing—Estradiol—osteoporosis	0.000686	0.00118	CcSEcCtD
Flecainide—Arthralgia—Conjugated Estrogens—osteoporosis	0.000684	0.00117	CcSEcCtD
Flecainide—Chest pain—Conjugated Estrogens—osteoporosis	0.000684	0.00117	CcSEcCtD
Flecainide—Myalgia—Conjugated Estrogens—osteoporosis	0.000684	0.00117	CcSEcCtD
Flecainide—Asthenia—Ibandronate—osteoporosis	0.000683	0.00117	CcSEcCtD
Flecainide—Anxiety—Conjugated Estrogens—osteoporosis	0.000682	0.00117	CcSEcCtD
Flecainide—Nausea—Etidronic acid—osteoporosis	0.000682	0.00117	CcSEcCtD
Flecainide—Oedema—Zoledronate—osteoporosis	0.000681	0.00117	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00068	0.00116	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000679	0.00116	CcSEcCtD
Flecainide—Diarrhoea—Estropipate—osteoporosis	0.000679	0.00116	CcSEcCtD
Flecainide—Gastrointestinal disorder—Risedronate—osteoporosis	0.000677	0.00116	CcSEcCtD
Flecainide—Fatigue—Risedronate—osteoporosis	0.000676	0.00116	CcSEcCtD
Flecainide—Insomnia—Pamidronate—osteoporosis	0.000675	0.00116	CcSEcCtD
Flecainide—Pruritus—Ibandronate—osteoporosis	0.000674	0.00115	CcSEcCtD
Flecainide—Constipation—Risedronate—osteoporosis	0.000671	0.00115	CcSEcCtD
Flecainide—Pain—Risedronate—osteoporosis	0.000671	0.00115	CcSEcCtD
Flecainide—Shock—Zoledronate—osteoporosis	0.00067	0.00115	CcSEcCtD
Flecainide—Paraesthesia—Pamidronate—osteoporosis	0.00067	0.00115	CcSEcCtD
Flecainide—Diarrhoea—Alendronate—osteoporosis	0.000669	0.00115	CcSEcCtD
Flecainide—Asthenia—Calcitriol—osteoporosis	0.000669	0.00115	CcSEcCtD
Flecainide—Nervous system disorder—Zoledronate—osteoporosis	0.000668	0.00114	CcSEcCtD
Flecainide—Immune system disorder—Estradiol—osteoporosis	0.000667	0.00114	CcSEcCtD
Flecainide—Thrombocytopenia—Zoledronate—osteoporosis	0.000667	0.00114	CcSEcCtD
Flecainide—Dyspnoea—Pamidronate—osteoporosis	0.000665	0.00114	CcSEcCtD
Flecainide—Tachycardia—Zoledronate—osteoporosis	0.000665	0.00114	CcSEcCtD
Flecainide—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000663	0.00114	CcSEcCtD
Flecainide—Somnolence—Pamidronate—osteoporosis	0.000663	0.00114	CcSEcCtD
Flecainide—Skin disorder—Zoledronate—osteoporosis	0.000662	0.00113	CcSEcCtD
Flecainide—Pruritus—Calcitriol—osteoporosis	0.000659	0.00113	CcSEcCtD
Flecainide—Hyperhidrosis—Zoledronate—osteoporosis	0.000659	0.00113	CcSEcCtD
Flecainide—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000658	0.00113	CcSEcCtD
Flecainide—Diarrhoea—Raloxifene—osteoporosis	0.000658	0.00113	CcSEcCtD
Flecainide—Dyspepsia—Pamidronate—osteoporosis	0.000656	0.00112	CcSEcCtD
Flecainide—Dizziness—Estropipate—osteoporosis	0.000656	0.00112	CcSEcCtD
Flecainide—Oedema—Conjugated Estrogens—osteoporosis	0.000656	0.00112	CcSEcCtD
Flecainide—Alopecia—Estradiol—osteoporosis	0.000653	0.00112	CcSEcCtD
Flecainide—Diarrhoea—Ibandronate—osteoporosis	0.000651	0.00112	CcSEcCtD
Flecainide—Anorexia—Zoledronate—osteoporosis	0.000649	0.00111	CcSEcCtD
Flecainide—Decreased appetite—Pamidronate—osteoporosis	0.000648	0.00111	CcSEcCtD
Flecainide—Dizziness—Alendronate—osteoporosis	0.000647	0.00111	CcSEcCtD
Flecainide—Shock—Conjugated Estrogens—osteoporosis	0.000645	0.00111	CcSEcCtD
Flecainide—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000644	0.0011	CcSEcCtD
Flecainide—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000643	0.0011	CcSEcCtD
Flecainide—Fatigue—Pamidronate—osteoporosis	0.000643	0.0011	CcSEcCtD
Flecainide—Gastrointestinal pain—Risedronate—osteoporosis	0.000642	0.0011	CcSEcCtD
Flecainide—Tachycardia—Conjugated Estrogens—osteoporosis	0.00064	0.0011	CcSEcCtD
Flecainide—Urticaria—Ethinyl Estradiol—osteoporosis	0.000639	0.0011	CcSEcCtD
Flecainide—Pain—Pamidronate—osteoporosis	0.000638	0.00109	CcSEcCtD
Flecainide—Constipation—Pamidronate—osteoporosis	0.000638	0.00109	CcSEcCtD
Flecainide—Diarrhoea—Calcitriol—osteoporosis	0.000638	0.00109	CcSEcCtD
Flecainide—Skin disorder—Conjugated Estrogens—osteoporosis	0.000637	0.00109	CcSEcCtD
Flecainide—Hypotension—Zoledronate—osteoporosis	0.000637	0.00109	CcSEcCtD
Flecainide—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000636	0.00109	CcSEcCtD
Flecainide—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000636	0.00109	CcSEcCtD
Flecainide—Dizziness—Raloxifene—osteoporosis	0.000636	0.00109	CcSEcCtD
Flecainide—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000634	0.00109	CcSEcCtD
Flecainide—Flatulence—Estradiol—osteoporosis	0.000634	0.00109	CcSEcCtD
Flecainide—Tension—Estradiol—osteoporosis	0.000631	0.00108	CcSEcCtD
Flecainide—Vomiting—Estropipate—osteoporosis	0.000631	0.00108	CcSEcCtD
Flecainide—Dysgeusia—Estradiol—osteoporosis	0.00063	0.00108	CcSEcCtD
Flecainide—Dizziness—Ibandronate—osteoporosis	0.00063	0.00108	CcSEcCtD
Flecainide—Rash—Estropipate—osteoporosis	0.000626	0.00107	CcSEcCtD
Flecainide—Dermatitis—Estropipate—osteoporosis	0.000625	0.00107	CcSEcCtD
Flecainide—Anorexia—Conjugated Estrogens—osteoporosis	0.000625	0.00107	CcSEcCtD
Flecainide—Nervousness—Estradiol—osteoporosis	0.000625	0.00107	CcSEcCtD
Flecainide—Urticaria—Risedronate—osteoporosis	0.000623	0.00107	CcSEcCtD
Flecainide—Headache—Estropipate—osteoporosis	0.000622	0.00107	CcSEcCtD
Flecainide—Vomiting—Alendronate—osteoporosis	0.000622	0.00107	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000621	0.00106	CcSEcCtD
Flecainide—Abdominal pain—Risedronate—osteoporosis	0.00062	0.00106	CcSEcCtD
Flecainide—Body temperature increased—Risedronate—osteoporosis	0.00062	0.00106	CcSEcCtD
Flecainide—Rash—Alendronate—osteoporosis	0.000616	0.00106	CcSEcCtD
Flecainide—Insomnia—Zoledronate—osteoporosis	0.000616	0.00106	CcSEcCtD
Flecainide—Dermatitis—Alendronate—osteoporosis	0.000616	0.00106	CcSEcCtD
Flecainide—Feeling abnormal—Pamidronate—osteoporosis	0.000615	0.00105	CcSEcCtD
Flecainide—Hypotension—Conjugated Estrogens—osteoporosis	0.000613	0.00105	CcSEcCtD
Flecainide—Headache—Alendronate—osteoporosis	0.000613	0.00105	CcSEcCtD
Flecainide—Paraesthesia—Zoledronate—osteoporosis	0.000612	0.00105	CcSEcCtD
Flecainide—Vomiting—Raloxifene—osteoporosis	0.000611	0.00105	CcSEcCtD
Flecainide—Gastrointestinal pain—Pamidronate—osteoporosis	0.00061	0.00104	CcSEcCtD
Flecainide—Dyspnoea—Zoledronate—osteoporosis	0.000607	0.00104	CcSEcCtD
Flecainide—Rash—Raloxifene—osteoporosis	0.000606	0.00104	CcSEcCtD
Flecainide—Dermatitis—Raloxifene—osteoporosis	0.000606	0.00104	CcSEcCtD
Flecainide—Somnolence—Zoledronate—osteoporosis	0.000606	0.00104	CcSEcCtD
Flecainide—Vomiting—Ibandronate—osteoporosis	0.000605	0.00104	CcSEcCtD
Flecainide—Tremor—Estradiol—osteoporosis	0.000603	0.00103	CcSEcCtD
Flecainide—Headache—Raloxifene—osteoporosis	0.000602	0.00103	CcSEcCtD
Flecainide—Rash—Ibandronate—osteoporosis	0.0006	0.00103	CcSEcCtD
Flecainide—Dermatitis—Ibandronate—osteoporosis	0.0006	0.00103	CcSEcCtD
Flecainide—Dyspepsia—Zoledronate—osteoporosis	0.0006	0.00103	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000598	0.00102	CcSEcCtD
Flecainide—Ill-defined disorder—Estradiol—osteoporosis	0.000597	0.00102	CcSEcCtD
Flecainide—Headache—Ibandronate—osteoporosis	0.000596	0.00102	CcSEcCtD
Flecainide—Insomnia—Conjugated Estrogens—osteoporosis	0.000593	0.00102	CcSEcCtD
Flecainide—Vomiting—Calcitriol—osteoporosis	0.000593	0.00102	CcSEcCtD
Flecainide—Decreased appetite—Zoledronate—osteoporosis	0.000592	0.00101	CcSEcCtD
Flecainide—Nausea—Estropipate—osteoporosis	0.00059	0.00101	CcSEcCtD
Flecainide—Abdominal pain—Pamidronate—osteoporosis	0.00059	0.00101	CcSEcCtD
Flecainide—Body temperature increased—Pamidronate—osteoporosis	0.00059	0.00101	CcSEcCtD
Flecainide—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000589	0.00101	CcSEcCtD
Flecainide—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000588	0.00101	CcSEcCtD
Flecainide—Rash—Calcitriol—osteoporosis	0.000588	0.00101	CcSEcCtD
Flecainide—Fatigue—Zoledronate—osteoporosis	0.000587	0.00101	CcSEcCtD
Flecainide—Dermatitis—Calcitriol—osteoporosis	0.000587	0.00101	CcSEcCtD
Flecainide—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000585	0.001	CcSEcCtD
Flecainide—Headache—Calcitriol—osteoporosis	0.000584	0.001	CcSEcCtD
Flecainide—Somnolence—Conjugated Estrogens—osteoporosis	0.000583	0.000999	CcSEcCtD
Flecainide—Pain—Zoledronate—osteoporosis	0.000583	0.000998	CcSEcCtD
Flecainide—Constipation—Zoledronate—osteoporosis	0.000583	0.000998	CcSEcCtD
Flecainide—Nausea—Alendronate—osteoporosis	0.000581	0.000995	CcSEcCtD
Flecainide—Malaise—Estradiol—osteoporosis	0.00058	0.000994	CcSEcCtD
Flecainide—Vertigo—Estradiol—osteoporosis	0.000578	0.00099	CcSEcCtD
Flecainide—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000577	0.000989	CcSEcCtD
Flecainide—Asthenia—Ethinyl Estradiol—osteoporosis	0.000577	0.000989	CcSEcCtD
Flecainide—Syncope—Estradiol—osteoporosis	0.000577	0.000988	CcSEcCtD
Flecainide—Nausea—Raloxifene—osteoporosis	0.000571	0.000979	CcSEcCtD
Flecainide—Decreased appetite—Conjugated Estrogens—osteoporosis	0.00057	0.000977	CcSEcCtD
Flecainide—Pruritus—Ethinyl Estradiol—osteoporosis	0.000569	0.000975	CcSEcCtD
Flecainide—Palpitations—Estradiol—osteoporosis	0.000568	0.000974	CcSEcCtD
Flecainide—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000566	0.00097	CcSEcCtD
Flecainide—Fatigue—Conjugated Estrogens—osteoporosis	0.000566	0.000969	CcSEcCtD
Flecainide—Nausea—Ibandronate—osteoporosis	0.000565	0.000969	CcSEcCtD
Flecainide—Loss of consciousness—Estradiol—osteoporosis	0.000565	0.000969	CcSEcCtD
Flecainide—Asthenia—Risedronate—osteoporosis	0.000563	0.000964	CcSEcCtD
Flecainide—Feeling abnormal—Zoledronate—osteoporosis	0.000561	0.000962	CcSEcCtD
Flecainide—Cough—Estradiol—osteoporosis	0.000561	0.000962	CcSEcCtD
Flecainide—Pain—Conjugated Estrogens—osteoporosis	0.000561	0.000961	CcSEcCtD
Flecainide—Constipation—Conjugated Estrogens—osteoporosis	0.000561	0.000961	CcSEcCtD
Flecainide—Gastrointestinal pain—Zoledronate—osteoporosis	0.000557	0.000954	CcSEcCtD
Flecainide—Hypertension—Estradiol—osteoporosis	0.000555	0.000952	CcSEcCtD
Flecainide—Pruritus—Risedronate—osteoporosis	0.000555	0.000951	CcSEcCtD
Flecainide—Nausea—Calcitriol—osteoporosis	0.000554	0.000948	CcSEcCtD
Flecainide—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000551	0.000943	CcSEcCtD
Flecainide—Myalgia—Estradiol—osteoporosis	0.000548	0.000938	CcSEcCtD
Flecainide—Arthralgia—Estradiol—osteoporosis	0.000548	0.000938	CcSEcCtD
Flecainide—Chest pain—Estradiol—osteoporosis	0.000548	0.000938	CcSEcCtD
Flecainide—Anxiety—Estradiol—osteoporosis	0.000546	0.000935	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000544	0.000932	CcSEcCtD
Flecainide—Urticaria—Zoledronate—osteoporosis	0.000541	0.000927	CcSEcCtD
Flecainide—Discomfort—Estradiol—osteoporosis	0.000541	0.000927	CcSEcCtD
Flecainide—Abdominal pain—Zoledronate—osteoporosis	0.000539	0.000923	CcSEcCtD
Flecainide—Body temperature increased—Zoledronate—osteoporosis	0.000539	0.000923	CcSEcCtD
Flecainide—Diarrhoea—Risedronate—osteoporosis	0.000537	0.00092	CcSEcCtD
Flecainide—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000536	0.000919	CcSEcCtD
Flecainide—Dry mouth—Estradiol—osteoporosis	0.000536	0.000918	CcSEcCtD
Flecainide—Asthenia—Pamidronate—osteoporosis	0.000535	0.000917	CcSEcCtD
Flecainide—Dizziness—Ethinyl Estradiol—osteoporosis	0.000532	0.000912	CcSEcCtD
Flecainide—Confusional state—Estradiol—osteoporosis	0.000529	0.000907	CcSEcCtD
Flecainide—Pruritus—Pamidronate—osteoporosis	0.000528	0.000904	CcSEcCtD
Flecainide—Oedema—Estradiol—osteoporosis	0.000525	0.000899	CcSEcCtD
Flecainide—Urticaria—Conjugated Estrogens—osteoporosis	0.000521	0.000893	CcSEcCtD
Flecainide—Dizziness—Risedronate—osteoporosis	0.000519	0.000889	CcSEcCtD
Flecainide—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000519	0.000888	CcSEcCtD
Flecainide—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000519	0.000888	CcSEcCtD
Flecainide—Shock—Estradiol—osteoporosis	0.000516	0.000885	CcSEcCtD
Flecainide—Nervous system disorder—Estradiol—osteoporosis	0.000515	0.000882	CcSEcCtD
Flecainide—Tachycardia—Estradiol—osteoporosis	0.000512	0.000878	CcSEcCtD
Flecainide—Vomiting—Ethinyl Estradiol—osteoporosis	0.000512	0.000877	CcSEcCtD
Flecainide—Diarrhoea—Pamidronate—osteoporosis	0.00051	0.000874	CcSEcCtD
Flecainide—Skin disorder—Estradiol—osteoporosis	0.00051	0.000874	CcSEcCtD
Flecainide—Hyperhidrosis—Estradiol—osteoporosis	0.000508	0.00087	CcSEcCtD
Flecainide—Rash—Ethinyl Estradiol—osteoporosis	0.000507	0.000869	CcSEcCtD
Flecainide—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000507	0.000868	CcSEcCtD
Flecainide—Headache—Ethinyl Estradiol—osteoporosis	0.000504	0.000864	CcSEcCtD
Flecainide—Vomiting—Risedronate—osteoporosis	0.000499	0.000855	CcSEcCtD
Flecainide—Rash—Risedronate—osteoporosis	0.000495	0.000848	CcSEcCtD
Flecainide—Dermatitis—Risedronate—osteoporosis	0.000494	0.000847	CcSEcCtD
Flecainide—Dizziness—Pamidronate—osteoporosis	0.000493	0.000845	CcSEcCtD
Flecainide—Headache—Risedronate—osteoporosis	0.000491	0.000842	CcSEcCtD
Flecainide—Asthenia—Zoledronate—osteoporosis	0.000489	0.000837	CcSEcCtD
Flecainide—Pruritus—Zoledronate—osteoporosis	0.000482	0.000826	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000478	0.00082	CcSEcCtD
Flecainide—Nausea—Ethinyl Estradiol—osteoporosis	0.000478	0.000819	CcSEcCtD
Flecainide—Insomnia—Estradiol—osteoporosis	0.000475	0.000814	CcSEcCtD
Flecainide—Vomiting—Pamidronate—osteoporosis	0.000474	0.000812	CcSEcCtD
Flecainide—Paraesthesia—Estradiol—osteoporosis	0.000471	0.000808	CcSEcCtD
Flecainide—Asthenia—Conjugated Estrogens—osteoporosis	0.000471	0.000806	CcSEcCtD
Flecainide—Rash—Pamidronate—osteoporosis	0.00047	0.000806	CcSEcCtD
Flecainide—Dermatitis—Pamidronate—osteoporosis	0.00047	0.000805	CcSEcCtD
Flecainide—Dyspnoea—Estradiol—osteoporosis	0.000468	0.000802	CcSEcCtD
Flecainide—Headache—Pamidronate—osteoporosis	0.000467	0.000801	CcSEcCtD
Flecainide—Somnolence—Estradiol—osteoporosis	0.000467	0.0008	CcSEcCtD
Flecainide—Diarrhoea—Zoledronate—osteoporosis	0.000466	0.000799	CcSEcCtD
Flecainide—Nausea—Risedronate—osteoporosis	0.000466	0.000798	CcSEcCtD
Flecainide—Pruritus—Conjugated Estrogens—osteoporosis	0.000464	0.000795	CcSEcCtD
Flecainide—Dyspepsia—Estradiol—osteoporosis	0.000462	0.000792	CcSEcCtD
Flecainide—Decreased appetite—Estradiol—osteoporosis	0.000456	0.000782	CcSEcCtD
Flecainide—Gastrointestinal disorder—Estradiol—osteoporosis	0.000453	0.000777	CcSEcCtD
Flecainide—Fatigue—Estradiol—osteoporosis	0.000453	0.000775	CcSEcCtD
Flecainide—Dizziness—Zoledronate—osteoporosis	0.00045	0.000772	CcSEcCtD
Flecainide—Pain—Estradiol—osteoporosis	0.000449	0.000769	CcSEcCtD
Flecainide—Constipation—Estradiol—osteoporosis	0.000449	0.000769	CcSEcCtD
Flecainide—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000449	0.000769	CcSEcCtD
Flecainide—Nausea—Pamidronate—osteoporosis	0.000443	0.000759	CcSEcCtD
Flecainide—Dizziness—Conjugated Estrogens—osteoporosis	0.000434	0.000743	CcSEcCtD
Flecainide—Vomiting—Zoledronate—osteoporosis	0.000433	0.000742	CcSEcCtD
Flecainide—Feeling abnormal—Estradiol—osteoporosis	0.000433	0.000741	CcSEcCtD
Flecainide—Rash—Zoledronate—osteoporosis	0.00043	0.000736	CcSEcCtD
Flecainide—Gastrointestinal pain—Estradiol—osteoporosis	0.000429	0.000736	CcSEcCtD
Flecainide—Dermatitis—Zoledronate—osteoporosis	0.000429	0.000735	CcSEcCtD
Flecainide—Headache—Zoledronate—osteoporosis	0.000427	0.000731	CcSEcCtD
Flecainide—Vomiting—Conjugated Estrogens—osteoporosis	0.000417	0.000715	CcSEcCtD
Flecainide—Urticaria—Estradiol—osteoporosis	0.000417	0.000715	CcSEcCtD
Flecainide—Abdominal pain—Estradiol—osteoporosis	0.000415	0.000711	CcSEcCtD
Flecainide—Body temperature increased—Estradiol—osteoporosis	0.000415	0.000711	CcSEcCtD
Flecainide—Rash—Conjugated Estrogens—osteoporosis	0.000414	0.000709	CcSEcCtD
Flecainide—Dermatitis—Conjugated Estrogens—osteoporosis	0.000413	0.000708	CcSEcCtD
Flecainide—Headache—Conjugated Estrogens—osteoporosis	0.000411	0.000704	CcSEcCtD
Flecainide—Nausea—Zoledronate—osteoporosis	0.000405	0.000693	CcSEcCtD
Flecainide—Nausea—Conjugated Estrogens—osteoporosis	0.00039	0.000668	CcSEcCtD
Flecainide—Asthenia—Estradiol—osteoporosis	0.000377	0.000645	CcSEcCtD
Flecainide—Pruritus—Estradiol—osteoporosis	0.000371	0.000636	CcSEcCtD
Flecainide—Diarrhoea—Estradiol—osteoporosis	0.000359	0.000615	CcSEcCtD
Flecainide—Dizziness—Estradiol—osteoporosis	0.000347	0.000595	CcSEcCtD
Flecainide—Vomiting—Estradiol—osteoporosis	0.000334	0.000572	CcSEcCtD
Flecainide—Rash—Estradiol—osteoporosis	0.000331	0.000567	CcSEcCtD
Flecainide—Dermatitis—Estradiol—osteoporosis	0.000331	0.000567	CcSEcCtD
Flecainide—Headache—Estradiol—osteoporosis	0.000329	0.000563	CcSEcCtD
Flecainide—Nausea—Estradiol—osteoporosis	0.000312	0.000534	CcSEcCtD
